Teva Posts Strong Results After Stormy Fourth Quarter

World's largest generic drug maker reports 6% increase in profit, beating analysts’ forecasts.

and
comments Print
Teva Pharmaceuticals, the world’s largest generic drug maker, earned $1.42 a share excluding one-time items in the fourth quarter of 2013, up 10 cents from a year earlier, lifted by higher prices for its...
skip all comments

Comments

Sign in to join the conversation.

Required field
Required field

By adding a comment, I agree to this site’s Terms of use

  1. 1